New Antimalarial Shows Promise in First-in-Human Clinical Trial
NEW YORK (Reuters Health) – M5717, a new antimalarial being developed by Merck KGaA (Germany) ...
Single-Dose Typhoid Vaccine 84% Effective in Africa Trial
NEW YORK (Reuters Health) – A single dose of...
Malaria Vaccine + Antimalarial = 70% Reduction in Disease, Death
A new study from Africa shows a remarkable 70% red...
BioNTech Eyes Rwanda, Senegal for Malaria, Tuberculosis Vaccine Production
(Reuters) – COVID-19 vaccine maker BioNTech ...